Massive Growth in Animal Stem Cell Therapy Market Breaking new grounds and touch new level in Upcoming Year by VETSTEM BIOPHARMA, MediVet Biologic,…

Animal Stem Cell Therapy Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Animal Stem Cell Therapy Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Get the PDF Sample Copy of This Report:

https://www.a2zmarketresearch.com/sample?reportId=134420

Key Players Profiled in This Report:

VETSTEM BIOPHARMA, MediVet Biologic, J-ARM, Celavet, Magellan Stem Cells, U.S. Stem Cell, Cells Power Japan, ANIMAL CELL THERAPIES, Animal Care Stem, Cell Therapy Sciences, VetCell Therapeutics, Animacel, Aratana Therapeutics

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Animal Stem Cell Therapy market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Animal Stem Cell Therapy markets trajectory between forecast periods.

Get 20% Discount on this Premium Report at:

https://www.a2zmarketresearch.com/discount?reportId=134420

Reasons for buying this report:

Table of Contents:

Global Animal Stem Cell Therapy Market Research Report

Chapter 1 Animal Stem Cell Therapy Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Animal Stem Cell Therapy Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=134420

Read more from the original source:
Massive Growth in Animal Stem Cell Therapy Market Breaking new grounds and touch new level in Upcoming Year by VETSTEM BIOPHARMA, MediVet Biologic,...

Cancer struck Welsh mum so aggressively it cracked her ribs and damaged her spine – North Wales Live

A mum-of-two suffered cracked ribs and small holes in her spine due to an aggressive form of cancer.

The pain in her chest and spine was so severe Susie Suter could barely walk, so she decided to go see a doctor who booked her in for a series of hospital scans.

The scans showed that Susie's cancer had spread all across her body, damaging her spine and sternum.

Susie, 51, told WalesOnline : "I'm so grateful that I was with my mother at the time because I was deeply shocked by the news."

"I just couldn't believe it. I had been fit and healthy all my life and felt so young. I thought I was looking at a terminal illness. The consultant looked devastated when he told me."

Susie was eventually diagnosed with multiple myeloma, a cancer that develops in white blood cells called plasma cells, in August 2013, at the age of 44.

"I was so relieved to have a diagnosis," admitted mum-of-two Susie, the owner of the Gliffaes Country House Hotel in Crickhowell, Powys.

"The worst bit was not knowing what it was and feeling so anxious about what would happen to me.

"My daughters were in the middle of their exams at school and I was worried about how they would feel. It was a relief to get some answers."

At the Velindre Cancer Centre in Cardiff, Susie had radiotherapy treatment. She also received chemotherapy under the care of Nevill Hall Hospital in Abergavenny.

Her best chance of survival, according to doctors, was to undergo a stem cell transplant to help her body make new healthy blood cells after her own had been damaged by the disease.

She underwent the transplant in March, 2014 during which time she spent three weeks in an isolation ward.

Susie, wife to James Suter, 54, and mum to Alexandra, 25, and Olivia, 23, added: "I found this part of my treatment incredibly hard. I felt so sick and tired and I lost a lot of weight and eventually all my hair.

"It took me a long time to feel myself again after this, although the medical team were excellent and helped me to get through it."

Six months after the transplant, Susie said her energy levels had returned, and after a year she began to feel like she had done before her diagnosis.

Since then she has accomplished sporting and non-sporting challenges for charity, including a fundraising bike ride from London to Paris.

She also completed the last 20 miles of a 1,000-mile virtual cycling challenge with her friend and personal trainer Mike James in lockdown while she was shielding at home.

Susie has also hosted fundraising coffee mornings and raised funds for Cancer Research UK with an annual Christmas carol evening at her hotel.

Ever since her transplant five years ago she has been on a Cancer Research UK-supported clinical research trial involving the drug Revlimid which has kept her feeling well.

But last year she suffered a blow when she was told she had relapsed and might need another stem cell transplant in the future. Susie currently has regular bone-strengthening treatments at Nevill Hall Hospital.

By sharing her remarkable story, Susie hopes to inspire people across Wales to donate to Cancer Research UK to get lifesaving work back on track.

"Research gives me, my family, and friends the hope we need," she said.

"It's thanks to improved treatments that I've been given more precious time with my loved ones. It upsets me to think about research being delayed and what this might mean for people affected by cancer in the months and years to come."

After the cancellation of fundraising events like Race for Life, Cancer Research UK is expecting a staggering 160m drop in income in the year ahead.

As a result, the charity said it had been forced to take the difficult decision to cut 44m in research funding -but this is likely to be just the beginning.

Cassandra Miles, Cancer Research UK spokeswoman for Wales, said: "Were grateful to Susie for helping to underline the stark reality of the current situation.

"Covid-19 put so much of our research on pause, leaving us facing a crisis where every day and every pound counts.

"With around 19,500 people diagnosed with cancer each year in Wales, we will never stop striving to create better treatments. But we cant do it alone.

"Whether they donate, sign up to Race for Life at Home or shop at our stores - with the help of people in Wales, we believe that together we will still beat cancer. Donate now at cruk.org/give."

Cancer Research UK was able to spend nearly 4m in Wales last year on some of the UK's leading scientific and clinical research.

Continue reading here:
Cancer struck Welsh mum so aggressively it cracked her ribs and damaged her spine - North Wales Live

12 Incredible inventions to make you feel Proudly South African – The South African

Did you know that it was the Council for Scientific and Industrial Research in South Africa made lithium batteries a reality? How about the CAT scan? Yes, that it is a South African invention too.

Its a little-known fact but according to theSable Network, South Africa is a world leader in everything from cell culturing to microsatellites and the technologies of flight.

Lets look at a list of other breakthroughs in science and medicine that South Africans can be proud of. How many were you aware of?

One of the most famous inventions to come of out of South Africa has to be the CAT scan or Computed Axial Tomography Scan. It was created by physicists Allan Cormack and Godfrey Hounsfield in 1972.

An X-ray source and electronic detectors rotate around the patients body and collect all the data needed to produce a cross-section of the body.

Sasol previously know as the South African Gas Distribution Company was founded in 1950 when the government realised that our country had oil reserves.

To this day, Sasol remains theworlds first and largest oil-from-coal refineryand produces approximately 40% of all fuel used in South Africa.

Dr Chris Barnard famouslyperformed the worlds first hearttransplant in 1967 on Louis Washkansky, who volunteered for the groundbreaking surgery.

The success of the first heart transplant turned Dr Barnard into somewhat of a celebrity on the international scene, and he performed ten more transplants throughout his career.

On 3 March 2019, Professor Mashudu Tshifularo became the first person to transplant 3D-printed bones for reconstructive middle ear implants, at the Steve Biko Academic Hospital.

Prof Tshifularo, who is the head of the Department of Ear, Nose, and Throat and Head and Neck Surgery at theOtorhinolaryngologyDepartment of theUniversity of Pretoria, developed the echnology during his PhD studies.

The patients who received the reconstructive middle ear implants was a 40-year-old with accidental trauma damage, and a 62-year-old with a middle ear issue and a history of failed interventions.

The CSIRs Gene Expression and Biophysics groupdesigned the first induced pluripotent stem cells in Africa, which opened the door for researchers to investigate various diseases and cures.

Stem cells could be used to restore sight or repair cells affected by heart disease, amongst other things. The possibilities are endless and are still being explored.

South Africas most well-known invention is most probably the Kreepy Krauly. It wasdeveloped by Ferdinand Chauvier from Springsin the mid-seventies.

Basically a vacuum cleaner for a swimming pool, it collects debris and takes the hassle out of pool cleaning, leaving pool-owners with more time to relax next to the pool instead of cleaning it.

George Pratley initially wanted to create a type of glue to hold electrical components and inadvertently created something much stronger.

It wasdeveloped in the late sixties,and even help sent man to the moon! Pratleys Putty was famously used by Apollo XI during the Moon Landing to hold bits of the landing craft together. Yep, a South African invention made sure those astronauts returned home safe and sound.

In 1950, a Mr Robertson from Pinetown, KwaZulu Natal, invented the lubrication we know today as Q20. He was discussing the merits of the spray with his neighbour soon after inventing it, saying that the spray has 20 answers to 20 questions.

He did not know how else describe the effective water repellent which not only keeps rust at bay, but also eases squeaky door hinges, and also eases rusted and seized nuts and bolts.

Today, its one of South Africas most-loved products.

Back in the early 2000s Mark Shuttleworth created Ubuntu, and open-source Linux-based operating system. The first version of Ubuntu was released in October 2004, and Shuttle announced the creation of the Ubunut Foundation in July the following yea.

The purpose of the foundation is to ensure the support anddevelopmentfor all future versions of Ubuntu. Shuttleworth said the foundations goal was to ensure the continuity of the Ubuntu project. Indeed, today Im writing this article on Ubuntu. Thank you, Mark.

The worlds first digital laser wasinvented by doctoral candidate, and CSIR researcher, Dr Sandile Nqcobo, and the former minister of Science and Technology cited it as a testimony to the calibre of scientists that South Africa has.

The laser is used in the health sector, and its numerous applications could also be used to improve the communication sector.

A new method used in cataract surgery was created at the Baragwanath hospital in Soweto in the mid-seventies by a specialist in retinal diseases, Selig Percy Amoils.

Amoils received the Queens Award for Technological Innovation, and his cryoprobe was later displayed at the prestigious Kensington Museum.

The scanner wascreated by Lodox Systems,a South African company that created the full-body scanner from technology that was initially designed for the security sector for the detection of stolen diamonds.

The use of the full-body scanner was written into the storyline of Greys Anatomy during the shows ninth season when the Grace Mercy West Hospital installed the scanner in their new ER department.

The three-piece single-use syringe was specially designed in 1999 by several doctors at the Vaal University of Technology to provide increased protection against needle-stick injury.

In the era of Ebola, Hepatitis and HIV, the safety syringe has saved countless lives..

Bonus round! We already mentioned Professor Mashudu Tshifularo and the first transplant of 3D-printed bones, Mark Shuttleworths Ubuntu and Dr Sandile Ngcobos Digital Laser further up.

However, are a few more proudly South African inventions from the 21st century.

Continue reading here:
12 Incredible inventions to make you feel Proudly South African - The South African

Stem Cell Market Status by Upcoming Trends 2020 Growth Drivers | Competitive Strategy, Regional Outlook with SWOT Analysis till 2024 – Owned

Stem cells banking is gaining importance with the support of government initiatives. The number of stem cell banks is increasing in developing countries, which is aiding the growth of the market. Also, increasing awareness about stem cell storage among the people has positively affected the market. Currently, the market is not well established in many therapeutic areas and has shown nascent success in history. However, it holds great potential in both the diagnosis and therapeutic fields.

Scope of the Report:

The scope of this market is limited to tracking the stem cell market. As per the scope of this report, stem cells are biological cells that can differentiate into other types of cells. Also, various types of stem cells are used for therapeutic purposes.

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999718

Key Market Trends:

Oncology Disorders Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Cancer has a major impact on society in the United States and across the world. As per the estimation of National Cancer Institute, in 2018, 1,735,350 new cases of cancer were anticipated to get diagnosed in the United States, and 609,640 deaths were expected from the disease. This increasing medical burden is due to population growth. Bone marrow transplant or stem cell transplant is a treatment for some types of cancers, like leukemia, multiple myeloma, multiple myeloma, neuroblastoma, or some types of lymphoma.

Embryonic stem cells (ESC) are the major source of stem cells for therapeutic purposes, due to their higher totipotency and indefinite lifespan, as compared to adult stem cells with lower totipotency and restricted lifespan. However, the use of ESCs for research and therapeutic purposes is restricted and prohibited in many countries throughout the world, due to some ethical constraints. Scientists from the University of California, Irvine, created the stem cell-based approach to kill cancerous tissue while preventing some toxic side effects of chemotherapy by treating the disease in a more localized way.

Although the market shows positive growth, due to the growing focus of stem cell-based research that can further strengthen the clinical application, its expensive nature for stem cell therapy may still hamper its growth.

North America Captured The Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall stem cell market with the United States contributing to the largest share in the market. In 2014, the Sanford Stem Cell Clinical Center at the University of California, San Diego (UCSD) Health System, announced the launch of a clinical trial, in order to assess the safety of neural stem cell-based therapy in patients with chronic spinal cord injury. Researchers hoped that the transplanted stem cells may develop into new neurons that could replace severed or lost nerve connections, and restore at least some motor and sensory functions. Such numerous stem cell studies across the United States have helped in the growth of the stem cell market.

The report provides key statistics on the market status of the Stem Cell Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Stem Cell .

Purchase this Report (Price 4250 USD for a single-user license) https://www.industryresearch.co/purchase/13999718

Key Insights of Stem Cell Market:

Stem Cell Market Report Covers Following Points in TOC:

For Detailed TOC Click Here

Contact Us:

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Foramen Ovale Electrodes Market: Global Industry Size with Trends 2020, Comprehensive Research by Development Status, Opportunities, and Competitive Landscape with COVID-19 outbreak

IGZO Display Market Size by Top Key Players 2020 Global Growth Rate by Share, Industry Segment, Future Prospect, Key Finding and Market Dynamics Forecast to 2026

Crystalline Silicon Photovoltaic Market Size, Trends 2020 Global Industry by Manufacturers Growth Rate | COVID-19 Impact on Future Scope, Demand Status, Business Strategy Forecast to 2026

Fava Beans Market 2020 Trends, Manufacturing Size, Growth Analysis by Share, Top Regions, Driving Factors of Manufacturers, Types and Applications Forecast to 2023

Portable Abrasive Blasters Market Size by Top Key Players 2020 Global Growth Rate by Share, Industry Segment, Future Prospect, Key Finding and Market Dynamics Forecast to 2026

Pressure Ulcers Treatment Market Size and Growth Rate 2020 | Global Impact of COVID-19 on Industry Share, Explosive Factors of Key Players, Progress Status, and Recent Trends Forecast to 2026

Read more:
Stem Cell Market Status by Upcoming Trends 2020 Growth Drivers | Competitive Strategy, Regional Outlook with SWOT Analysis till 2024 - Owned

Massive Growth in Stem Cell Banking Market Breaking new grounds and touch new level in Upcoming Year by Cord Blood Registry Systems, Cordlife,…

Stem Cell Banking Market report focused on the comprehensive analysis of current and future prospects of the Stem Cell Banking industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Stem Cell Banking market has been done in order to calculate the growth rates for each segment and sub-segments.

Stem Cell Banking Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Get Sample Copy (Including FULL TOC, Graphs and Tables) of this report:

https://www.a2zmarketresearch.com/sample?reportId=139887

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Vendors of this Market are:

Cord Blood Registry Systems, Cordlife, Cryo-Cell International, Cryo-Save Ag (A Subsidiary Of Esperite N.V), Lifecell International, Stemcyte, Viacord (A Subsidiary Of Perkinelmer), Global Cord Blood, Smart Cells International, Vita34, Cryoholdco

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Stem Cell Banking market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Stem Cell Banking markets trajectory between forecast periods.

The report provides insights on the following pointers:

Hurry Up! Get Upto 20% Discount on this Report @:

https://www.a2zmarketresearch.com/discount?reportId=139887

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Stem Cell Banking market. It focuses on the major points, which are necessary to make positive impacts on the market policies, international transactions, speculation, and supply demand in the global market.

Reasons for buying this report:

Table of Contents

Global Stem Cell Banking Market Research Report 2020 2026

Chapter 1 Stem Cell Banking Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Stem Cell Banking Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=139887

If you have any special requirements, please let us know and we will offer you the report as you want.

Read more here:
Massive Growth in Stem Cell Banking Market Breaking new grounds and touch new level in Upcoming Year by Cord Blood Registry Systems, Cordlife,...

Stem Cell Therapy for Diabetes and Related Conditions Market analysis with Leading Key Players and Regional Analysis 2026 – CueReport

The Global Stem Cell Therapy for Diabetes and Related Conditions market report offers key information about the industry, helpful and important facts and figures, expert opinions, and the latest developments across the world. The research report represents a comprehensive presumption of the market and encloses imperative future estimations, industry-authenticated figures, and facts of the global market. It predicts inclinations and augmentation statistics with emphasis on abilities & technologies, markets & industries along with the variable market trends. The Stem Cell Therapy for Diabetes and Related Conditions market report analyses and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire Stem Cell Therapy for Diabetes and Related Conditions market.

The Stem Cell Therapy for Diabetes and Related Conditions market report intends to offer significant information of this business space while elaborating on the key global trends. The document emphasizes on the growth opportunities as well as the drivers that will influence the profitability graph of this business vertical over the estimated timeframe. It also measures the challenges & restraints that may inhibit the expansion of the market.

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/25032

The research repot delivers a comparative statement regarding the existing and predicted market scenario to derive the growth rate of this industry vertical over the study duration. Additionally, it measures the effect of COVID-19 outbreak on the regional as well as overall market to denote the methodologies that can help in decision making.

Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/25032

Major details from Table of Contents:

Product landscape

Application scope

Regional Analysis

Competitive arena

In short, the Stem Cell Therapy for Diabetes and Related Conditions market provides a granular assessment through numerous segmentations, while evaluating the other aspects including sales channel and supply chain processes which consist of downstream buyers, upstream suppliers, and distributors of this business space.

Key Answers Captured in Study Objectives are

Request Customization on This Report @ https://www.cuereport.com/request-for-customization/25032

More:
Stem Cell Therapy for Diabetes and Related Conditions Market analysis with Leading Key Players and Regional Analysis 2026 - CueReport

Report: The Impact of COVID-19 On Global Angelman Syndrome Treatment Market : Dynamics, Segments, Size and Demand, 2018 2028 – The Cloud Tribune

Angelman syndrome is a rare genetic disorder that primarily affects the nervous system. It is estimated that, Angelman syndrome disorder usually occurs in one in 12,000 to 20,000 people in the general population. Angelman syndrome is caused by a loss of function in the UBE3A gene on the maternal 15th chromosome. People suffering from Angelman syndrome frequently laugh and smile, and have excitable personalities. The symptoms of Angelman syndrome include seizures, lack of speech, and balance issues. Other symptoms are tongue thrusting, developmental delays, jerky movements, small head size with flatness in the back of the head, and others. Request Free Sample Report https://www.factmr.com/connectus/sample?flag=S&rep_id=1309

The angelman syndrome treatment market report examines the operating pattern of each player new product launches, partnerships, and acquisitions has been examined in detail. Important regions covered in the angelman syndrome treatment market report include:

North America Latin America Europe Japan APEJ MEA

The angelman syndrome treatment market report takes into consideration the following segments by product type:

Physical Therapy Communication Therapy Behavior Therapy Others The angelman syndrome treatment market report contain the following end uses:

Hospitals Specialty Clinics Ambulatory Surgical Centers Others The angelman syndrome treatment market report offers a plethora of insights which include:

Changing consumption pattern among individuals globally. Historical and future progress of the global angelman syndrome treatment market. Region-wise and country-wise segmentation of the angelman syndrome treatment market to understand the revenue, and growth lookout in these areas. Accurate Year-on-Year growth of the global angelman syndrome treatment market. Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global angelman syndrome treatment market. Have Any Query? Ask our Industry Expertshttps://www.factmr.com/connectus/sample?flag=AE&rep_id=1309

Pertinent aspects this study on the Angelman Syndrome Treatment market tries to answer exhaustively are:

What is the forecast size (revenue/volumes) of the most lucrative regional market? What is the share of the dominant product/technology segment in the Angelman Syndrome Treatment market? What regions are likely to witness sizable investments in research and development funding? What are Covid 19 implication on Angelman Syndrome Treatment market and learn how businesses can respond, manage and mitigate the risks? Which countries will be the next destination for industry leaders in order to tap new revenue streams? Which new regulations might cause disruption in industry sentiments in near future? Which is the share of the dominant end user? Which region is expected to rise at the most dominant growth rate? Which technologies will have massive impact of new avenues in the Angelman Syndrome Treatment market? Which key end-use industry trends are expected to shape the growth prospects of the Angelman Syndrome Treatment market? What factors will promote new entrants in the Angelman Syndrome Treatment market? What is the degree of fragmentation in the Angelman Syndrome Treatment market, and will it increase in coming years? Why Choose Fact.MR? Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

Read more:
Report: The Impact of COVID-19 On Global Angelman Syndrome Treatment Market : Dynamics, Segments, Size and Demand, 2018 2028 - The Cloud Tribune

Mum had tumour so big it cracked her ribs – Wales Online

When mum Susie Suter began suffering with pain that was so severe in her chest and spine that she struggled to walk, she knew it was time to see a doctor.

But the news he gave her was so shocking, she said even the consultant looked "devastated".

She'd had to undergo a serious of hospital scans which confirmed cancer. It was a cancer that had spread all over her body and even damaged her spine and sternum.

In fact, the disease had become so aggressive that small holes had formed in her vertebrae and the tumours had caused several of her ribs to crack.

Susie, 51, said: "I'm so grateful that I was with my mother at the time because I was deeply shocked by the news."

"I just couldn't believe it. I had been fit and healthy all my life and felt so young. I thought I was looking at a terminal illness. The consultant looked devastated when he told me."

After further tests and biopsies, Susie's results were discussed by doctors at Nevill Hall Hospital in Abergavenny, as well as members of the All Wales Lymphoma panel, a group of experts who specialise in blood cancers in Wales.

Eventually, in August, 2013, at the age of 44, Susie was diagnosed with multiple myeloma, a cancer that develops in white blood cells called plasma cells.

"I was so relieved to have a diagnosis," admitted mum-of-two Susie, the owner of the Gliffaes Country House Hotel in Crickhowell, Powys.

"The worst bit was not knowing what it was and feeling so anxious about what would happen to me.

"My daughters were in the middle of their exams at school and I was worried about how they would feel. It was a relief to get some answers."

Susie had radiotherapy treatment at the Velindre Cancer Centre in Cardiff and was under the care of Nevill Hall Hospital for chemotherapy.

Doctors had advised Susie that her best chance of survival would be a stem cell transplant.

In March, 2014, she underwent the transplant to help her body make new healthy blood cells after her own had been damaged by the disease.

It meant three weeks in an isolation ward while she had chemotherapy before she was given her "clean" stem cells back.

Susie, wife to James Suter, 54, and mum to Alexandra, 25, and Olivia, 23, added: "I found this part of my treatment incredibly hard. I felt so sick and tired and I lost a lot of weight and eventually all my hair.

"It took me a long time to feel myself again after this, although the medical team were excellent and helped me to get through it."

Six months after the transplant, Susie said her energy levels had returned, and after a year she began to feel like she had done before her diagnosis.

Since then she has accomplished sporting and non-sporting challenges for charity, including a fundraising bike ride from London to Paris.

She also completed the last 20 miles of a 1,000-mile virtual cycling challenge with her friend and personal trainer Mike James in lockdown while she was shielding at home.

Susie has also hosted fundraising coffee mornings and raised funds for Cancer Research UK with an annual Christmas carol evening at her hotel.

Ever since her transplant five years ago she has been on a Cancer Research UK-supported clinical research trial involving the drug Revlimid which has kept her feeling well.

But last year she suffered a blow when she was told she had relapsed and might need another stem cell transplant in the future. Susie currently has regular bone-strengthening treatments at Nevill Hall Hospital.

By sharing her remarkable story, Susie hopes to inspire people across Wales to donate to Cancer Research UK to get lifesaving work back on track.

"Research gives me, my family, and friends the hope we need," she said.

"It's thanks to improved treatments that I've been given more precious time with my loved ones. It upsets me to think about research being delayed and what this might mean for people affected by cancer in the months and years to come."

After the cancellation of fundraising events like Race for Life, Cancer Research UK is expecting a staggering 160m drop in income in the year ahead.

As a result, the charity said it had been forced to take the difficult decision to cut 44m in research funding -but this is likely to be just the beginning.

Cassandra Miles, Cancer Research UK spokeswoman for Wales, said: "Were grateful to Susie for helping to underline the stark reality of the current situation.

"Covid-19 put so much of our research on pause, leaving us facing a crisis where every day and every pound counts.

"With around 19,500 people diagnosed with cancer each year in Wales, we will never stop striving to create better treatments. But we cant do it alone.

"Whether they donate, sign up to Race for Life at Home or shop at our stores - with the help of people in Wales, we believe that together we will still beat cancer. Donate now atcruk.org/give."

Cancer Research UK was able to spend nearly 4m in Wales last year on some of the UK's leading scientific and clinical research.

Go here to see the original:
Mum had tumour so big it cracked her ribs - Wales Online

Association between race and treatment patterns and survival outcomes in multiple myeloma: A connect MM registry analysis – DocWire News

This article was originally published here

Cancer. 2020 Jul 24. doi: 10.1002/cncr.33089. Online ahead of print.

ABSTRACT

BACKGROUND: Studies have reported racial disparities in access to and use of multiple myeloma (MM) treatments between African American (AA) and White patients. Although AA patients demonstrate longer disease-specific survival, this has not uniformly translated into improved survival over time. The association between race and treatment patterns and survival outcomes was analyzed using data from the Connect MM Registry.

METHODS: The Connect MM Registry is a large US, multicenter, prospective observational cohort study of patients with newly diagnosed MM. Patients who received first-line (1L) stem cell transplantation (SCT) or who did not receive SCT (non-SCT or non-stem cell transplantation [NSCT]) were grouped by raceEffects of race and transplantation status on the use of triplet treatment were estimated using logistic regression.

RESULTS: Treatment patterns in 1L (types and duration of induction, posttransplantation maintenance) were similar between AA and White patients. SCT rates in 1L (32% vs 36%) and triplet treatment use (AA: 44% for NSCT patients and 72% for SCT patients; and White: 48% for NSCT patients and 72% for SCT patients) during first induction were similar. No significant effect of race or transplantation status on 1L triplet treatment use was observed. Race was not found to be associated with survival outcomes among patients who underwent NSCT; however, AA patients who received SCT had significantly longer overall survival compared with White patients who underwent SCT (not reached vs 88.2 months; hazard ratio, 0.56; 95% CI, 0.35-0.89 [P = .0141]).

CONCLUSIONS: AA and White patients were found to have similar treatment patterns in the Connect MM Registry, suggesting that both groups had equal access to health care. In this real-world setting, AA patients received standard-of-care treatment, which might have contributed to better MM-specific survival compared with White patients.

PMID:32706404 | DOI:10.1002/cncr.33089

View post:
Association between race and treatment patterns and survival outcomes in multiple myeloma: A connect MM registry analysis - DocWire News

New Study Offers First Glimpse Into How Widespread COVID-19 Antibodies are in Canada’s Adult Population – Canada NewsWire

Initial results indicate fewer than 1 in 100 blood donations have antibodies to the novel coronavirus that causes COVID-19.

MONTREAL, OTTAWA, ON, and TORONTO, July 23, 2020 /CNW Telbec/ -Today, Canadian Blood Services and Canada's COVID-19 Immunity Task Force (CITF) are releasing initial results of the first 10,000 blood donor samples assessed for SARS-CoV-2 antibodies. This analysis reveals that over the period from May 9 through June 8, 2020, fewer than 1 per cent of the 10,000 samples from blood donors tested positive for antibodies to the novel coronavirus. Antibodies indicate past infection with SARS-CoV-2, and population studies like this one tell us how many people have likely been exposed to the virus.

These results offer a first, high-level glimpse into an ongoing Canadian Blood Services study assessing SARS-CoV-2 antibodies across nine provinces. They will be updated once Canadian Blood Services completes their analysis of the full sample of 37,800 donations made during the months of May and June 2020. In addition, Hma-Qubec will have results for Quebec in the near future, which will be important for a complete national picture, given the COVID-19 rates in that province.

While there will be adjustments to this initial figure once the full 10-province study is completed in the coming weeks, Professor Catherine Hankins, CITF Co-Chair, believes its implications bear public attention immediately, as reopening is causing a worrisome uptick in COVID-19 cases across Canada.

"What is clear is that only a small percentage of adult Canadians has been infected by SARS-CoV-2," Hankins says. "By far, the majority of us remain vulnerable to infection. We need to ramp up testing and tracing capacity across the country to interrupt any chains of transmission quickly to prevent unchecked spread."

CITF Co-Chair Professor David Naylor concurred: "These data suggest there are several undetected infections for every case confirmed with swabs and RNA tests. That lends weight to current public health advice. Please wear a mask in public indoor spaces, wash your hands often, and practice physical distancing if you're around people who aren't in your COVID-19 'bubble'."

Acknowledging that many more adult Canadians are infected than currently documented, Professor Timothy Evans, CITF Executive Director cautioned against over-interpreting the apparent reduction in risk. "Among adults, the death rate from being infected with SARS-CoV-2 is likely closer to one per cent, as compared to the eight per cent reported to date among those diagnosed with COVID-19. But this is a highly infective virus that could take a huge toll if we allow it to spread, and we are only now learning that many survivors have persistent symptoms."

These initial results from Canadian Blood Services and CITF are a first step toward giving policymakers a deeper understanding of the COVID-19 infection rate across Canada. As further samples are analyzed by Canadian Blood Services and Hma-Qubec, the findings will offer new insights to help guide effective public health measures.

"I want to thank Canadians for the sacrifices made to flatten the curve in the first wave. While these first results reflect widespread adherence with public health measures, they also mean most Canadians remain susceptible to infection,"says the Honourable Patty Hajdu, Minister of Health."As we start to see case numbers rise again, we all need to follow public health advice and avoid crowded places, close-contact settings and confined spaces."

When the Government of Canada established CITF in late April 2020, Canadian Blood Services and Hma-Qubec reached out to offer their assistance. Canada's blood system became the first place the initiative looked for evidence of infection and immunity in the Canadian population.

The choice was obvious. Blood donation centres are a rapid and reliable resource for generating insights into the patterns of illness, such as COVID-19, in the broader population. Canadian Blood Services and Hma-Qubec routinely test blood donations, including tests for pathogens that can be transmitted through transfusion (SARS-CoV2 is not known to be transfusion-transmitted). Both organizations also regularly contribute to active, ethics-approved research programs like this one, some of which in the past have included seroprevalence work to guide policies.

"Canadian Blood Services is proud to support the CITF's mandate," says Dr. Graham Sher, Chief Executive Officer, Canadian Blood Services. "We are uniquely positioned to help by providing information on the presence of COVID-19 antibodies in a large number of people across Canada relatively quickly. This is a great opportunity and privilege for blood donors and staff at Canadian Blood Services to contribute to a national need in a novel way."

"Getting an early picture of the levels of population immunity is critical to inform the public health response," says Dr. Marc Germain, Vice-President, Medical Affairs and Innovation, Hma-Qubec. "We look forward in the coming days to sharing the results of the first study on antibodies to SARS-CoV-2 among blood donors in Quebec."

About the COVID-19 Immunity Task Force

The Government of Canada launched the COVID-19 Immunity Task Force in late April 2020 to measure the scope of coronavirus infection in Canada and rapidly provide information to manage the COVID-19 pandemic and safely get Canadians back to work. The Task Force has the mission of ensuring that at least one million Canadian blood samples are collected and tested over the next two years to track the spread of the virus in the general population and shed light on immune responses to it in a diversity of communities, settings, age brackets, and occupational groups across the nation. For more information visit: http://www.covid19immunitytaskforce.ca

About Canadian Blood Services

Canadian Blood Services is a not-for-profit charitable organization. Regulated by Health Canada as a biologics manufacturer and primarily funded by the provincial and territorial ministries of health, Canadian Blood Services operates with a national scope, infrastructure and governance that make it unique within Canadian healthcare. In the domain of blood, plasma, and stem cells, we provide services for patients on behalf of all provincial and territorial governments, except Quebec. The national transplant registry for interprovincial organ sharing and related programs reaches into all provinces and territories, as a biological lifeline for Canadians. For more information visit: blood.ca

SOURCE McGill University

For further information: Media contacts: COVID-19 Immunity Task Force, Katherine Gombay, [emailprotected] / [emailprotected], 514-717-2289; Canadian Blood Services, [emailprotected], 1-877-709-7773

http://www.mcgill.ca

Read the rest here:
New Study Offers First Glimpse Into How Widespread COVID-19 Antibodies are in Canada's Adult Population - Canada NewsWire